Investing.comCodex · 实盘不做把握 4/10
北京时间·🕒 发布 07-22 19:20:33时区推断·⟳ 抓取 07-22 19:21:20·⚡ 决策 07-23 08:54:08 +13h32m·96.6 天前
Trinity Biotech将实施1比30反向ADS拆分以恢复纳斯达克合规
公司将ADS比例由1 ADS代表20股普通股改为1 ADS代表600股普通股，相当于1比30反向ADS拆分。
📄 原文Investing.com↗ 原文
Trinity Biotech plans 1-for-30 reverse ADS split
Oil price tops $95 for first time since June 11 amid widening Mideast conflict DUBLIN - Trinity Biotech plc (NASDAQ:TRI…
不做 Trinity Biotech（TRIB.US）
反向ADS拆分是最低价合规机械调整，虽偏负面但不构成明确强空催化，且未核实可借券，当前不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-22 · 扩散 medium · price-in 风险 medium ↗
关键理由
- 公司将ADS比例由1 ADS代表20股普通股改为1 ADS代表600股普通股，相当于1比30反向ADS拆分。
- 公司明确称目的是恢复纳斯达克1美元最低买入价合规，并便利不能购买5美元以下证券的投资者。
主要风险
- 反向拆分本身不改变基本面，短线方向通常偏负面但不是足够强的可执行做空催化。
工具调用 · 历史记录,结果未知(2 种)
- search_processed_events · 结果未知
- stock_quote · 结果未知
原文全文
展开原文 · 1,712 字
Oil price tops $95 for first time since June 11 amid widening Mideast conflict
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB) announced plans to change its American depositary share ratio from one ADS representing 20 Class A ordinary shares to one ADS representing 600 Class A ordinary shares, according to a press release statement.
The ratio change will take effect at the open of trading on Thursday and functions as a one-for-30 reverse ADS split. The company stated the adjustment aims to regain compliance with Nasdaq’s $1.00 minimum bid price requirement and facilitate investment from investors unable to purchase securities trading below $5.00.
ADS holders must surrender every 30 existing ADSs to receive one new ADS through The Bank of New York Mellon, the depositary bank. The ADSs will continue trading on the Nasdaq Global Market under the symbol TRIB.
The company’s Class A ordinary shares remain unchanged by this action.
Fractional entitlements to new ADSs will not be issued. The depositary will aggregate and sell fractional entitlements, distributing net cash proceeds to applicable ADS holders after deducting fees, taxes and expenses.
Trinity Biotech stated the ADS price is expected to increase proportionally following the ratio change but provided no assurance the post-split price will equal or exceed 30 times the pre-split price.
The company is a commercial-stage biotechnology firm focused on human diagnostics and diabetes management solutions. Trinity Biotech sells products directly in the United States and through distributors and strategic partners in over 75 countries.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB) announced plans to change its American depositary share ratio from one ADS representing 20 Class A ordinary shares to one ADS representing 600 Class A ordinary shares, according to a press release statement.
The ratio change will take effect at the open of trading on Thursday and functions as a one-for-30 reverse ADS split. The company stated the adjustment aims to regain compliance with Nasdaq’s $1.00 minimum bid price requirement and facilitate investment from investors unable to purchase securities trading below $5.00.
ADS holders must surrender every 30 existing ADSs to receive one new ADS through The Bank of New York Mellon, the depositary bank. The ADSs will continue trading on the Nasdaq Global Market under the symbol TRIB.
The company’s Class A ordinary shares remain unchanged by this action.
Fractional entitlements to new ADSs will not be issued. The depositary will aggregate and sell fractional entitlements, distributing net cash proceeds to applicable ADS holders after deducting fees, taxes and expenses.
Trinity Biotech stated the ADS price is expected to increase proportionally following the ratio change but provided no assurance the post-split price will equal or exceed 30 times the pre-split price.
The company is a commercial-stage biotechnology firm focused on human diagnostics and diabetes management solutions. Trinity Biotech sells products directly in the United States and through distributors and strategic partners in over 75 countries.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。